Results 211 to 220 of about 69,694 (262)
Some of the next articles are maybe not open access.
Circulation Research, 2017
Dilated cardiomyopathy is defined by the presence of left ventricular dilatation and contractile dysfunction. Genetic mutations involving genes that encode cytoskeletal, sarcomere, and nuclear envelope proteins, among others, account for up to 35% of cases. Acquired causes include myocarditis and exposure to alcohol, drugs and toxins, and metabolic and
Elizabeth Mcnally
exaly +3 more sources
Dilated cardiomyopathy is defined by the presence of left ventricular dilatation and contractile dysfunction. Genetic mutations involving genes that encode cytoskeletal, sarcomere, and nuclear envelope proteins, among others, account for up to 35% of cases. Acquired causes include myocarditis and exposure to alcohol, drugs and toxins, and metabolic and
Elizabeth Mcnally
exaly +3 more sources
The Lancet, 2010
Dilated cardiomyopathy is characterised by left ventricular dilation that is associated with systolic dysfunction. Diastolic dysfunction and impaired right ventricular function can develop. Affected individuals are at risk of left or right ventricular failure, or both. Heart failure symptoms can be exercise-induced or persistent at rest.
John Lynn, Jefferies, Jeffrey A, Towbin
openaire +2 more sources
Dilated cardiomyopathy is characterised by left ventricular dilation that is associated with systolic dysfunction. Diastolic dysfunction and impaired right ventricular function can develop. Affected individuals are at risk of left or right ventricular failure, or both. Heart failure symptoms can be exercise-induced or persistent at rest.
John Lynn, Jefferies, Jeffrey A, Towbin
openaire +2 more sources
Current Opinion in Cardiology, 1994
The etiology and pathogenesis of dilated cardiomyopathy continues to be controversial. The importance of viral and familial etiologies is becoming increasingly recognized. Molecular biology will add significantly to our understanding of these factors in the near future.
S C, Siu, M J, Sole
openaire +2 more sources
The etiology and pathogenesis of dilated cardiomyopathy continues to be controversial. The importance of viral and familial etiologies is becoming increasingly recognized. Molecular biology will add significantly to our understanding of these factors in the near future.
S C, Siu, M J, Sole
openaire +2 more sources
Idiopathic Dilated Cardiomyopathy
New England Journal of Medicine, 1994Valentin Fuster +2 more
exaly +3 more sources
Immunoadsorption in dilated cardiomyopathy
Transfusion and Apheresis Science, 2007Dilated cardiomyopathy (DCM) is a common myocardial disease characterized by ventricular dilatation and progressive depression of myocardial contractile function. Disturbances in both humoral and cellular immunity have been described among these patients. A number of antibodies against various cardiac cell proteins have been identified in DCM.
Alexander, Staudt, Stephan B, Felix
openaire +2 more sources
Alcoholic dilated cardiomyopathy
Nursing Standard, 2008This article provides an overview of alcoholic dilated cardiomyopathy. It aims to increase awareness of the condition among nurses, and help in early diagnosis and appropriate treatment referrals. The key message is that all patients with alcoholic dilated cardiomyopathy should be advised and assisted to stop drinking alcohol.
Anna, Adam +2 more
openaire +2 more sources
MYOCARDITIS AND DILATED CARDIOMYOPATHY
Annual Review of Medicine, 1987The recent developments in the study of myocarditis and dilated cardiomyopathy are reviewed here, with the primary emphasis on the issue of myocarditis as a precursor to dilated cardiomyopathy. Advances in immunologic approaches have expanded our knowledge of the course of myocarditis, experimentally as well as clinically.
C, Kawai, A, Matsumori, H, Fujiwara
openaire +2 more sources
Immunopathogenesis of dilated cardiomyopathies
Current Opinion in Cardiology, 1995Idiopathic dilated cardiomyopathy is a chronic heart muscle disorder of unknown etiology, but experimental and clinical evidence is accumulating that points to an immune pathogenesis in a subset of patients, and to the potential importance of myosin as an antigen. Most recent developments include evidence of cardiac- and disease-specific autoantibodies
J H, Goldman, W J, McKenna
openaire +2 more sources
Current Treatment Options in Cardiovascular Medicine, 2001
The management of patients with dilated cardiomyopathy (DCM) heart failure starts with the determination of the underlying diagnosis, definition of the hemodynamic character (eg, systolic, diastolic, valvular, right- and left-sided heart dysfunction), recognition of complicating factors (eg, atrial fibrillation, renal dysfunction), and consideration ...
openaire +2 more sources
The management of patients with dilated cardiomyopathy (DCM) heart failure starts with the determination of the underlying diagnosis, definition of the hemodynamic character (eg, systolic, diastolic, valvular, right- and left-sided heart dysfunction), recognition of complicating factors (eg, atrial fibrillation, renal dysfunction), and consideration ...
openaire +2 more sources